ImmuPharma (LON:IMM) Stock Price Up 3.4% – Here’s Why

Shares of ImmuPharma plc (LON:IMM) rose 3.4% during trading on Friday . The stock traded as high as GBX 4.70 and last traded at GBX 4.70. Approximately 729,994 shares were traded during mid-day trading, a decline of 80% from the average daily volume of 3,742,107 shares. The stock had previously closed at GBX 4.55.

ImmuPharma Stock Up 18.6%

The firm has a market capitalization of £27.10 million, a PE ratio of -6.06 and a beta of 3.02. The business’s fifty day moving average price is GBX 6.79 and its 200 day moving average price is GBX 8.36.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.